The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest

Prior to the 2025 American Heart Association (AHA) Scientific Sessions Meeting, Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP, discusses two recent papers that are influencing practice within the cardiovascular space.

Craig Beavers discusses recent developments in hypertension management and the clinical implications of the Bax Hypertension and Cardia-3 trials with Shelby Tungate, PharmD, BCPS, AACC, from the UNC Eshelman School of Pharmacy.

Host Craig Beavers discusses the validity of meta-analyses and highlights analyses from ESC 2025 with Bill Baker, PharmD, FCCP, FACC, FAHA.

Host Craig Beavers sits down with Lorenz van der Linden, a Belgian pharmacist, to dive deep into 2 groundbreaking trials from the European Society of Cardiology (ESC) 2025 Congress. They explore the ALONE-AF trial, which examined anticoagulation strategies for patients with atrial fibrillation after catheter ablation, and the AQUATIC trial, which investigated the role of aspirin in patients on ...

Following the European Society of Cardiology Congress 2025, experts sat down again with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, to discuss key findings from the meeting. Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, reviewed new data from the meeting and...

In this episode, host Craig Beavers sits down with Gary Owen, clinical pharmacist and manager of Population Health Pharmacy Services at Vanderbilt University Medical Center, to discuss the newly updated ACC/AHA hypertension guidelines and what they mean for pharmacists. Gary shares how his team supports primary care providers across the state through collaborative practice agreements, innovativ...

This week, host Craig Beavers tackles the upcoming European Society of Cardiology (ESC) Congress 2025, taking place August 29 through September 1, 2025.  Key data to keep an eye on will include the following: The VICTORION-Difference study of inclisiran in hyperlipidemia The Essence study of olezarsen in hypertriglyceridemia Multiple studies on early discontinuation of aspirin after percutaneo...

In this episode, Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, sat down with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, for an exciting discussion of several Hot Line trials at the upcoming European Society of Cardiology Congress 2025. Learn more about the...

This week, host Craig Beavers sat down with Tara Lech, PharmD, CACP, director of anticoagulation services at Beth Israel Lahey Health, to discuss recent findings from the COBBRA trial, which compared bleeding risk with rivaroxaban versus apixaban.

Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of Pharmacy, to discuss intravenous iron and its use in patients with heart failure, as well as findings from the FAIR-HF2 clinical trial. Show notes: Anker SD, Friede T, Butler J, et al. Intravenous ferric carboxymaltose in heart failure with iron deficiency (https:/...

Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee. Finks reviews exactly what concierge medicine is, as well as its role in cardio-kidney-metabolic health and her own research on compounded GLP-1 and GIP agonists in a pharmacist-managed cardiometabol...

Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at the Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions. In his work, Riello has researched the use of proactive messaging to providers to better implement new treatments, finding success with this approach.

Host Craig Beavers speaks with Orly Vardeny, PharmD, MS, a professor of medicine at the University of Minnesota. Vardeny discusses her own career path, the importance of mentors, and pharmacist involvement in clinical research, such as her work with the FINEARTS-HF study of finerenone in heart failure. Show Notes: FINEART trial: https://www.nejm.org/doi/abs/10.1056/NEJMoa2407107 (https://url....

Host Craig Beavers spoke with Lavinia Salama, PharmD, clinical assistant professor at the University of Wyoming, about cardio-kidney-metabolic syndrome and how pharmacists can be at the forefront of serving patients. Salama also discusses her work in rural communities and why pharmacists are so crucial for those patients. Show Notes: SELECT trial of semaglutide: https://www.nejm.org/doi/full/...

Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus. For more information: Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association (https://www.ahajournals.org/doi/...

This week, expert Steven Dunn, PharmD, FAHA, FCCP, BCCP, discusses the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Read the guidelines here: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309

This episode discussed multiple studies. See the list below for links to articles and relevant content: REVERSE-IT trial data: https://www.pharmacytimes.com/view/acc-2025-ticagrelor-antidote-restores-platelet-function-treats-bleeding https://evidence.nejm.org/doi/full/10.1056/EVIDoa210004 (https://evidence.nejm.org/doi/full/10.1056/EVIDoa2100047) FAIR-HF2 trial data: https://www.pharmacytim...